Literature DB >> 28739167

Establishment of NF-κB sensing and interleukin-4 secreting mesenchymal stromal cells as an "on-demand" drug delivery system to modulate inflammation.

Tzuhua Lin1, Jukka Pajarinen1, Akira Nabeshima1, Laura Lu1, Karthik Nathan1, Zhenyu Yao1, Stuart B Goodman2.   

Abstract

Chronic inflammation is associated with up-regulation of the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and excessive inflammatory cytokine secretion by M1 macrophages. The anti-inflammatory cytokine interleukin (IL)-4 converts pro-inflammatory M1 macrophages into an anti-inflammatory and tissue-regenerative M2 phenotype, thus reducing inflammation and enhancing tissue regeneration. We have generated NF-κB responsive, or constitutively active IL-4 expression lentiviral vectors transduced into murine bone marrow-derived mesenchymal stromal cells (MSCs). MSCs with a constitutively active IL-4 expression vector produced large quantities of IL-4 continuously, whereas IL-4 secretion was significantly induced by lipopolysaccharide (LPS) in the NF-κB sensing MSCs. In contrast, LPS had no effect on MSCs with IL-4 secretion driven by a constitutively active promoter. We also found that intermittent and continuous LPS treatment displayed distinct NF-κB activation profiles, and this regulation was independent of IL-4 signaling. The supernatant containing IL-4 from the LPS-treated MSCs suppressed M1 marker (inducible nitric oxide synthase [iNOS] and tumor necrosis factor alpha [TNFα]) expression and enhanced M2 marker (Arginase 1, CD206 and IL1 receptor antagonist [IL1Ra]) expression in primary murine macrophages. The IL-4 secretion at the basal, non-LPS induced level was sufficient to suppress TNFα and enhance Arginase 1 at a lower level, but had no significant effects on iNOS, CD206 and IL1Ra expression. Finally, IL-4 secretion at basal or LPS-induced levels significantly suppressed osteogenic differentiation of MSCs. Our findings suggest that the IL-4 secreting MSCs driven by NF-κB sensing or constitutive active promoter have great potential for mitigating the effects of chronic inflammation and promoting earlier tissue regeneration.
Copyright © 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NF-κB; interleukin-4; macrophage polarization; mesenchymal stromal cells

Mesh:

Substances:

Year:  2017        PMID: 28739167      PMCID: PMC5563472          DOI: 10.1016/j.jcyt.2017.06.008

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  55 in total

Review 1.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 2.  Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma.

Authors:  J B Aquino; M F Bolontrade; M G García; O L Podhajcer; G Mazzolini
Journal:  Gene Ther       Date:  2010-03-11       Impact factor: 5.250

3.  Decreased osteogenesis in mesenchymal stem cells derived from the aged mouse is associated with enhanced NF-κB activity.

Authors:  Tzu-Hua Lin; Emmanuel Gibon; Florence Loi; Jukka Pajarinen; Luis A Córdova; Akira Nabeshima; Laura Lu; Zhenyu Yao; Stuart B Goodman
Journal:  J Orthop Res       Date:  2016-05-18       Impact factor: 3.494

4.  Suppression of wear-particle-induced pro-inflammatory cytokine and chemokine production in macrophages via NF-κB decoy oligodeoxynucleotide: a preliminary report.

Authors:  Tzu-Hua Lin; Zhenyu Yao; Taishi Sato; Michael Keeney; Chenguang Li; Jukka Pajarinen; Fan Yang; Kensuke Egashira; Stuart B Goodman
Journal:  Acta Biomater       Date:  2014-05-09       Impact factor: 8.947

5.  A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.

Authors:  Ruth S Waterman; Suzanne L Tomchuck; Sarah L Henkle; Aline M Betancourt
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

6.  Il-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis.

Authors:  B Relic; J Guicheux; F Mezin; E Lubberts; D Togninalli; I Garcia; W B van den Berg; P A Guerne
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

7.  Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor(TLR)-4 and PI3K/Akt.

Authors:  Zhao-jun Wang; Fu-min Zhang; Lian-sheng Wang; Yong-wei Yao; Qiang Zhao; Xiang Gao
Journal:  Cell Biol Int       Date:  2009-04-17       Impact factor: 3.612

8.  Macrophages in bone fracture healing: Their essential role in endochondral ossification.

Authors:  Claudia Schlundt; Thaqif El Khassawna; Alessandro Serra; Anke Dienelt; Sebastian Wendler; Hanna Schell; Nico van Rooijen; Andreas Radbruch; Richard Lucius; Susanne Hartmann; Georg N Duda; Katharina Schmidt-Bleek
Journal:  Bone       Date:  2015-10-31       Impact factor: 4.398

Review 9.  Inflammation and mesenchymal stem cell aging.

Authors:  Günter Lepperdinger
Journal:  Curr Opin Immunol       Date:  2011-06-22       Impact factor: 7.486

10.  mTOR inhibition rescues osteopenia in mice with systemic sclerosis.

Authors:  Chider Chen; Kentaro Akiyama; Dandan Wang; Xingtian Xu; Bei Li; Alireza Moshaverinia; Frank Brombacher; Lingyun Sun; Songtao Shi
Journal:  J Exp Med       Date:  2014-12-22       Impact factor: 14.307

View more
  25 in total

1.  Trained murine mesenchymal stem cells have anti-inflammatory effect on macrophages, but defective regulation on T-cell proliferation.

Authors:  Tzuhua Lin; Jukka Pajarinen; Yusuke Kohno; Jhih-Fong Huang; Masahiro Maruyama; Monica Romero-Lopez; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  FASEB J       Date:  2018-12-06       Impact factor: 5.191

2.  Preconditioned or IL4-Secreting Mesenchymal Stem Cells Enhanced Osteogenesis at Different Stages.

Authors:  Tzuhua Lin; Yusuke Kohno; Jhih-Fong Huang; Monica Romero-Lopez; Masahiro Maruyama; Masaya Ueno; Jukka Pajarinen; Karthik Nathan; Zhenyu Yao; Fan Yang; Joy Y Wu; Stuart B Goodman
Journal:  Tissue Eng Part A       Date:  2019-03-27       Impact factor: 3.845

Review 3.  Immunobiology of periprosthetic inflammation and pain following ultra-high-molecular-weight-polyethylene wear debris in the lumbar spine.

Authors:  John H Werner; John H Rosenberg; Kristen L Keeley; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2018-08-21       Impact factor: 4.473

4.  Optimization and Characterization of Calcium Phosphate Transfection in Mesenchymal Stem Cells.

Authors:  Chi-Wen Lo; Tzuhua Lin; Masaya Ueno; Monica Romero-Lopez; Masahiro Maruyama; Yusuke Kohno; Claire Rhee; Zhenyu Yao; Magdiel Pérez-Cruz; Everett Meyer; Stuart B Goodman
Journal:  Tissue Eng Part C Methods       Date:  2019-09       Impact factor: 3.056

Review 5.  Designer Stem Cells: Genome Engineering and the Next Generation of Cell-Based Therapies.

Authors:  Farshid Guilak; Lara Pferdehirt; Alison K Ross; Yun-Rak Choi; KelseyH Collins; Robert J Nims; Dakota B Katz; Molly Klimak; Suzanne Tabbaa; Christine T N Pham
Journal:  J Orthop Res       Date:  2019-05-02       Impact factor: 3.494

Review 6.  Mesenchymal stem cell-macrophage crosstalk and bone healing.

Authors:  Jukka Pajarinen; Tzuhua Lin; Emmanuel Gibon; Yusuke Kohno; Masahiro Maruyama; Karthik Nathan; Laura Lu; Zhenyu Yao; Stuart B Goodman
Journal:  Biomaterials       Date:  2018-01-02       Impact factor: 12.479

7.  Transplanted interleukin-4--secreting mesenchymal stromal cells show extended survival and increased bone mineral density in the murine femur.

Authors:  Tzuhua Lin; Jukka Pajarinen; Yusuke Kohno; Masahiro Maruyama; Monica Romero-Lopez; Jhih-Fong Huang; Karthik Nathan; Tahsin N Khan; Zhenyu Yao; Stuart B Goodman
Journal:  Cytotherapy       Date:  2018-08-02       Impact factor: 5.414

8.  NFκB sensing IL-4 secreting mesenchymal stem cells mitigate the proinflammatory response of macrophages exposed to polyethylene wear particles.

Authors:  Tzuhua Lin; Yusuke Kohno; Jhih-Fong Huang; Monica Romero-Lopez; Jukka Pajarinen; Masahiro Maruyama; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2018-08-07       Impact factor: 4.396

9.  Interleukin-4 overexpressing mesenchymal stem cells within gelatin-based microribbon hydrogels enhance bone healing in a murine long bone critical-size defect model.

Authors:  Masaya Ueno; Chi-Wen Lo; Danial Barati; Bogdan Conrad; Tzuhua Lin; Yusuke Kohno; Takeshi Utsunomiya; Ning Zhang; Masahiro Maruyama; Claire Rhee; Ejun Huang; Monica Romero-Lopez; Xinming Tong; Zhenyu Yao; Stefan Zwingenberger; Fan Yang; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2020-05-14       Impact factor: 4.396

10.  [Early effect of graphene oxide-carboxymethyl chitosan hydrogel loaded with interleukin 4 and bone morphogenetic protein 2 on bone immunity and repair].

Authors:  Min Zou; Jiachen Sun; Zhou Xiang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.